Search results
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days agoALPHARETTA, Ga., April 30, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today
Kodiak Sciences Inc. (NASDAQ:KOD) Given Average Rating of “Reduce” by Analysts
ETF DAILY NEWS· 2 days agoKodiak Sciences Inc. (NASDAQ:KOD – Get Free Report) has been assigned an average rating of “Reduce” from the seven brokerages that are currently covering the stock, Marketbeat reports. Three ...
Small Business - Austin Daily Herald | Austin Daily Herald
Austin Daily Herald· 17 hours agoFirst quarter 2024 revenues decreased 1% to $3.15 billion versus first quarter 2023; excluding RonapreveTM(a)(b), revenues increased 7%First quarter 2024 Dupixent® global net sales (recorded by Sanofi) increased 24% to $3.08 billion versus first
Cwm LLC Sells 256 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 7 days agoCwm LLC lowered its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 9.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange ...
RWA Wealth Partners LLC Invests $375,000 in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 7 days agoRWA Wealth Partners LLC acquired a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing ...
Sigma Planning Corp Reduces Stake in REGENXBIO Inc. (NASDAQ:RGNX)
ETF DAILY NEWS· 4 days agoSigma Planning Corp lowered its position in REGENXBIO Inc. (NASDAQ:RGNX – Free Report) by 63.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities ...
Truist Financial Corp Sells 8,062 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 4 days agoTruist Financial Corp reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 15.4% in the fourth quarter, according to the company in its most recent ...
Regeneron Pharmaceuticals (NASDAQ:REGN) PT Raised to $1,030.00 at TD Cowen
ETF DAILY NEWS· 7 days agoRegeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its target price lifted by TD Cowen from $1,020.00 to $1,030.00 in a research report issued to clients and investors on Wednesday ...
